Safety and Efficacy of Six Months' Open Label Extension Post-RCT Using the Novel Cathepsin K Inhibitor MIV-711 in Patients With Knee Osteoarthritis
Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2019.02.564
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
Elsevier BV